Nutrition, Metabolism & Cardiovascular Diseases
Volume 22, Issue 3 , Pages 231-236 , March 2012

Non-cholesterol sterols in different forms of primary hyperlipemias

Received 7 February 2010 ,Revised 19 May 2010 ,Accepted 21 May 2010.

References 

  1. Bosner MS, Lange LG, Stenson WF, Ostlund RE. Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res. 1999;40:302–308
  2. Miettinen TA, Strandberg TE, Gylling H for the Finnish Investigators of the Scandinavian Simvastatin Survival Study Group. Arterioscler Thromb Vasc Biol. 2000;20:1340–1346
  3. Gylling H, Miettinen TA. Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption. J Lipid Res. 2002;43:1472–1476
  4. Berge KE, von Bergmann K, Lutjohann D, Guerra R, Grundy SM, Hobbs HH, et al. Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res. 2002;43:486–494
  5. Kesaniemi YA, Miettinen TA. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur J Clin Invest. 1987;17:391–395
  6. Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors reflect absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol. 1990;131:20–31
  7. Strandberg TE, Salomaa V, Vanhanen H, Miettinen TA. Associations of fasting blood glucose with cholesterol absorption and synthesis in non diabetic middLe aged men. Diabetes. 1996;45:755–761
  8. Pihlajamaki J, Gylling H, Miettinen TA, Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res. 2004;45:507–512
  9. Miettinen TA, Gylling H Subgroup analysis of Scandinavian Simvastatin Survival Study. Blood glucose and the metabolism of cholesterol in coronary patients with and without simvastatin treatment. Clin Chim Acta. 2007;379:53–58
  10. Hu FB, Stampfer MJ, Rimm EB, Manson JE, Ascherio A, Colditz GA, et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA. 1999;281:1387–1394
  11. Durrington P. Dyslipidemia. Lancet. 2003;362:717–731
  12. Hopkins PN, Heiss G, Ellison RC, Province MA, Pankow JS, Eckfeldt JH, et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation. 2003;108:519–523
  13. Genest JJ, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 1992;85:2025–2033
  14. Garcìa-Otın AL, Cofàn M, Junyent M, Recalde D, Cenarro A, Pocovì M, et al. Increased intestinal cholesterol absorption in autosomal dominant hypercholesterolemia and no mutations in the low-density lipoprotein receptor or apolipoprotein B genes. J Clin Endocrinol Metab. 2007;92:3667–3673
  15. van Himbergen TM, Otokozawa S, Matthan NR, Schaefer EJ, Buchsbaum A, Ai M, et al. Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway. Arterioscler Thromb Vasc Biol. 2010;30:113–120
  16. Ahmida HSM, Bertucci P, Franzò L, Massoud R, Cortese C, Lala A, et al. Simultaneous determination of plasmatic phytosterols and cholesterol precursors using gas chromatography-mass spectrometry (GC-MS) with selective ion monitoring (SIM). J Chromatogr B. 2006;842:43–47
  17. Simonen P, Gylling H, Howard AN, Miettinen TA. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr. 2000;72:82–88
  18. Knopp RH, Retzlaff B, Fish B, Walden C, Wallick S, Anderson M, et al. Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding. Arterioscler Thromb Vasc Biol. 2003;23:1437–1443
  19. Expert Panel on Detection , Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) . Executive summary of the Third Report of the National cholesterol Education Program (NCEP). JAMA. 2001;285:2486–2497
  20. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab. 2004;89:2601–2607
  21. Peltola P, Pihlajamäki J, Koutnikova H, Ruotsalainen E, Salmenniemi U, Vauhkonen I, et al. Visceral obesity is associated with high levels of serum squalene. Obesity. 2006;14:1155–1163
  22. Tobin KA, Ulven SM, Schuster GU, Steineger HH, Andresen SM, Gustafsson JA, et al. Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. J Biol Chem. 2002;277:10691–10697
  23. Yu L, York J, von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem. 2003;278:15565–15570
  24. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 2000;290:1771–1775
  25. Mannarino E, Pirro M, Cortese C, Lupattelli G, Siepi D, Mezzetti A, et al. Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study. Nutr Metab Cardiovasc Dis. 2009;19:84–90
  26. Cohen JC, Pertsemlidis A, Fahmi S, Esmail S, Vega GL, Grundy SM, et al. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci U S A. 2006;103:1810–1815
  27. Hubácek JA, Berge KE, Stefková J, Pitha J, Skodová Z, Lánská V, et al. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels. Physiol Res. 2004;53:395–401
  28. Kesaniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. Eur J Clin Invest. 1987;80:578–581
  29. Dreon DM, Femstrom HA, Miller B, Krauss RM. Apolipoprotein E isoform phenotype and LDL subclass response to a reduced fat diet. Arterioscler Thromb Vasc Biol. 1995;15:105–111
  30. Martin LJ, Connelly PW, Nancoo D, Wood N, Zhang ZJ, Maguire G, et al. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res. 1993;34:437–446
  31. Von Bergmann K, Lütjohann D, Lindenthal B, Steinmetz A. Efficiency of intestinal cholesterol absorption in humans is not related to apo E phenotype. J Lipid Res. 2003;44:193–197
  32. Ginsberg HN, Kris-Etherton P, Dennis B, Elmer PJ, Ershow A, Lefevre M, et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol. 1998;18:441–449
  33. Hayek T, Ito Y, Azrolan N, Verdery RB, Aalto-Setala K, Walsh A, et al. Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (apo) A–I. J Clin Invest. 1993;91:1665–1671

PII: S0939-4753(10)00133-X

doi: 10.1016/j.numecd.2010.05.010

Nutrition, Metabolism & Cardiovascular Diseases
Volume 22, Issue 3 , Pages 231-236 , March 2012

Article Tools